No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia. - PubMed - NCBI

No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia. - PubMed - NCBI

Acta Haematol. 2018 Feb 14;139(2):128-130. doi: 10.1159/000487071. [Epub ahead of print]

No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.

Brunner AM.

PMID:

 

29444505

 

DOI:

 

10.1159/000487071